Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |